相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Serum Exosome Derived MicroRNA-135a,-193b, and-384 Were Potential Alzheimer's Disease Biomarkers
Yang Ting Ting et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2018)
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease
Subodh Kumar et al.
HUMAN MOLECULAR GENETICS (2017)
MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles
Xiang-Yang Cao et al.
NEUROSCIENCE LETTERS (2017)
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease
Norikazu Hara et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease
Maria Satue et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease
Hui Dong et al.
BIOMARKERS (2016)
Serum miR-221 serves as a biomarker for Parkinson's disease
Wenbin Ma et al.
CELL BIOCHEMISTRY AND FUNCTION (2016)
Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease
LiYan Gao et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2015)
Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer's Disease: Baseline Data from a DIAN Cohort Subset
Pratishtha Chatterjee et al.
CURRENT ALZHEIMER RESEARCH (2015)
A test of lens opacity as an indicator of preclinical Alzheimer Disease
Ling Bei et al.
EXPERIMENTAL EYE RESEARCH (2015)
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Keith A. Vossel et al.
JOURNAL OF CELL BIOLOGY (2015)
Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3 signaling pathway
Juan Deng et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Evaluation of retinal nerve fiber layer thickness in Alzheimer disease using spectral-domain optical coherence tomography
Alime Gunes et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2015)
In Vivo Gastric Detection of α-Synuclein Inclusions in Parkinson's Disease
Alvaro Sanchez-Ferro et al.
MOVEMENT DISORDERS (2015)
Alterations of the Neuroinflammatory Markers IL-6 and TRAIL in Alzheimer's Disease
Ya-Ying Wu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2015)
Plasma proteins predict conversion to dementia from prodromal disease
Abdul Hye et al.
ALZHEIMERS & DEMENTIA (2014)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Beta-Amyloid, Phospho-Tau and Alpha-Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients
Cheng-Ying Ho et al.
BRAIN PATHOLOGY (2014)
MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
Takehiro Kiko et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
Daniela Galimberti et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Circulating miR-125b as a biomarker of Alzheimer's disease
Lin Tan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Development of a Prediction Formula of Parkinson Disease Severity by Optical Coherence Tomography
Beatriz Jimenez et al.
MOVEMENT DISORDERS (2014)
Skin nerve α-synuclein deposits A biomarker for idiopathic Parkinson disease
Vincenzo Donadio et al.
NEUROLOGY (2014)
Submandibular gland needle biopsy for the diagnosis of Parkinson disease
Charles H. Adler et al.
NEUROLOGY (2014)
Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease
Marwan S. M. Al-Nimer et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)
Optical Coherence Tomography in Parkinson's Disease: Is the Retina a Biomarker?
Jee-Young Lee et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Plasma Apolipoprotein A1 as a Biomarker for Parkinson Disease
Judy K. Qiang et al.
ANNALS OF NEUROLOGY (2013)
Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease
Ralph Michael et al.
EXPERIMENTAL EYE RESEARCH (2013)
Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease
Serkan Kirbas et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2013)
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients
Maria Teresa Pellecchia et al.
JOURNAL OF NEUROLOGY (2013)
Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls
Lucia F. Cardo et al.
JOURNAL OF NEUROLOGY (2013)
Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx
Liancai Mu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease
Pete A. Williams et al.
NEUROBIOLOGY OF AGING (2013)
Biomarkers in Parkinson's disease (recent update)
Sushil Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Discontinuation of statin therapy associates with Parkinson disease A population-based study
Yen-Chieh Lee et al.
NEUROLOGY (2013)
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Brit Mollenhauer et al.
NEUROSCIENCE LETTERS (2013)
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang et al.
JAMA NEUROLOGY (2013)
Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
S. Frost et al.
TRANSLATIONAL PSYCHIATRY (2013)
Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: an exploratory study
Charles Kerbage et al.
FRONTIERS IN NEUROLOGY (2013)
Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry
Xiaping Zhang et al.
ANALYST (2012)
Prospective Study of Statin Use and Risk of Parkinson Disease
Xiang Gao et al.
ARCHIVES OF NEUROLOGY (2012)
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease
Helene Pouclet et al.
NEUROBIOLOGY OF DISEASE (2012)
A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease
H. Pouclet et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
α-SYNUCLEIN PHOSPHORYLATION AND TRUNCATION ARE NORMAL EVENTS IN THE ADULT HUMAN BRAIN
G. Muntane et al.
NEUROSCIENCE (2012)
DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
Xiangmin Lin et al.
SCIENTIFIC REPORTS (2012)
Alzheimer disease and platelets: how's that relevant
Silvia Catricala et al.
IMMUNITY & AGEING (2012)
Plasma Epidermal Growth Factor Levels Predict Cognitive Decline in Parkinson Disease
Alice S. Chen-Plotkin et al.
ANNALS OF NEUROLOGY (2011)
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
Identification of blood microRNAs associated to Parkinsonis disease
Regina Margis et al.
JOURNAL OF BIOTECHNOLOGY (2011)
Alpha-Synuclein Immunoreactivity in Minor Salivary Gland Biopsies of Parkinson's Disease Patients
Maria Graciela Cersosimo et al.
MOVEMENT DISORDERS (2011)
Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease
Josef Marksteiner et al.
NEUROBIOLOGY OF AGING (2011)
Retinal thickness in Parkinson's disease
N. K. Archibald et al.
PARKINSONISM & RELATED DISORDERS (2011)
Potential role of retina as a biomarker for progression of Parkinson's disease
Tian Tian et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2011)
URATE AS A MARKER OF DEVELOPMENT AND PROGRESSION IN PARKINSON'S DISEASE
R. Constantinescu et al.
DRUGS OF TODAY (2011)
Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease
E. -S. Wang et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease
Kelly Del Tredici et al.
ACTA NEUROPATHOLOGICA (2010)
Plasma Urate and Parkinson's Disease in Women
Ellis J. O'Reilly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis
S. Cipriani et al.
BIOMARKERS IN MEDICINE (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Sensitive and Specific Detection of α-Synuclein in Human Plasma
R. B. Tinsley et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker
Tapan Kumar Khan et al.
NEUROBIOLOGY OF AGING (2010)
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Min Shi et al.
NEUROSCIENCE LETTERS (2010)
Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography
Yan Lu et al.
NEUROSCIENCE LETTERS (2010)
Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
Juliet A. Moncaster et al.
PLOS ONE (2010)
Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms
Thibaud Lebouvier et al.
PLOS ONE (2010)
Optical coherence tomography as a potential readout in clinical trials
Benjamin M. Greenberg et al.
Therapeutic Advances in Neurological Disorders (2010)
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Amyloid-Peptide Vaccinations Reduce β-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer's Transgenic Mice
Bingqian Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Inner Retinal Layer Thinning in Parkinson Disease
Mohammedyusuf E. Hajee et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
Guo Nan Yin et al.
BRAIN RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis
Kai-Yin Chau et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Biopsies of Olfactory Epithelium in Patients with Parkinson's Disease
Martin Witt et al.
MOVEMENT DISORDERS (2009)
β-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer's Disease
Sylvia E. Perez et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Diet, urate, and Parkinson's disease risk in men
Xiang Gao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Plasma β amyloid and the risk of Alzheimer disease and dementia in elderly men
Johan Sundelof et al.
ARCHIVES OF NEUROLOGY (2008)
Gout and the Risk of Parkinson's Disease: A Cohort Study
Mary De Vera et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinsons disease
Satoshi Orimo et al.
BRAIN (2008)
Pathological lesions in colonic biopsies during Parkinson's disease
T. Lebouvier et al.
GUT (2008)
Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR:: Implication for aggregation
Kuen-Phon Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Hiroshige Fujishiro et al.
MOVEMENT DISORDERS (2008)
Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease
Esther S. Oh et al.
NEUROMOLECULAR MEDICINE (2008)
Secretion of DJ-1 into the serum of patients with Parkinson's disease
Chinatsu Maita et al.
NEUROSCIENCE LETTERS (2008)
Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease
Jan Gruendemann et al.
NUCLEIC ACIDS RESEARCH (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease
Ozgul Altintas et al.
DOCUMENTA OPHTHALMOLOGICA (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
Mild Parkinsonian signs: An overview of an emerging concept
Elan D. Louis et al.
MOVEMENT DISORDERS (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease
G. F. Yavas et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
Forecasting the global burden of Alzheimer's disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2007)
The aging brain, a key target for the future: The protein kinase C involvement
Alessia Pascale et al.
PHARMACOLOGICAL RESEARCH (2007)
Retinal abnormalities in early Alzheimer's disease
Fatmire Berisha et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease
Pao-Chi Liao et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease
Daniel L. Alkon et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Proteome-based plasma biomarkers for Alzheimer's disease
A. Hye et al.
BRAIN (2006)
An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
Tapan K. Khan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Plasma Aβ1-40 and Aβ1-42 and the risk of dementia:: a prospective case-cohort study
Marieke van Oijen et al.
LANCET NEUROLOGY (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Alteration of protein kinase C conformation in red blood cells: A potential marker for Alzheimer's disease but not for Parkinson's disease
A Janoshazi et al.
NEUROBIOLOGY OF AGING (2006)
Role of genes and environments for explaining Alzheimer disease
M Gatz et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease
K Tang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Serum uric acid levels and the risk of Parkinson disease
LML de Lau et al.
ANNALS OF NEUROLOGY (2005)
Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography
M Wojtkowski et al.
OPHTHALMOLOGY (2005)
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease
AW Michell et al.
NEUROSCIENCE LETTERS (2005)
Mice transgenic for Alzheimer disease β-amyloid develop lens cataracts that are rescued by antioxidant treatment
S Melov et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease
A Hye et al.
NEUROSCIENCE LETTERS (2005)
Raman spectroscopic characterization of secondary structure in natively unfolded proteins:: α-synuclein
NC Maiti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Calpain mediates calcium-induced activation of the Erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons - Relevance to Alzheimer's disease
Veeranna et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
The importance of neuritic plaques and tangles to the development and evolution of AD
P Tiraboschi et al.
NEUROLOGY (2004)
Retinal nerve fiber layer thinning in Parkinson disease
R Inzelberg et al.
VISION RESEARCH (2004)
Plasma Aβ40 and Aβ42 and Alzheimer's disease -: Relation to age, mortality, and risk
R Mayeux et al.
NEUROLOGY (2003)
Age but not diagnosis is the main predictor of plasma amyloid β-protein levels
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2003)
Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease
LE Goldstein et al.
LANCET (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Aberrant profiles of native and oxidized glypoproteins in Alzheimer plasma
HL Yu et al.
PROTEOMICS (2003)
Lens defects and age-related fiber cell degeneration in a mouse model of increased APPP gene dosage in Down syndrome
PH Frederikse et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts
WQ Zhao et al.
NEUROBIOLOGY OF DISEASE (2002)
Identification of oxidized plasma proteins in Alzheimer's disease
JG Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
RC Petersen et al.
NEUROLOGY (2001)
Platelet APP isoform ratios correlate with declining cognition in AD
F Baskin et al.
NEUROLOGY (2000)
分享论文
